Ulster University Logo

Nutrient regulation of pancreatic beta-cell function in diabetes: problems and potential solutions

Flatt, Peter and Green, B. D. (2006) Nutrient regulation of pancreatic beta-cell function in diabetes: problems and potential solutions. BIOCHEMICAL SOCIETY TRANSACTIONS, 34 (Part 5). pp. 774-778. [Journal article]

Full text not available from this repository.


increasing prevalence of obesity combined with longevity will produce an epidemic of Type 2 (non-insulin-dependent) diabetes in the next 20 years. This. disease is associated with defects in insulin secretion, specifically abnormalities of insulin secretory kinetics and pancreatic beta-cell glucose responsiveness. Mechanisms underlying beta-cell dysfunction include glucose toxicity, lipotoxicity and beta-cell hyperactivity. Defects at various sites in beta-cell signal transduction pathways contribute, but no single lesion can account for the common form of Type 2 diabetes. Recent studies highlight diverse beta-cell actions of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These intestinal hormones target the beta-cell to stimulate glucose-dependent insulin secretion through activation of protein kinase A and associated pathways. Both increase gene expression and proinsulin biosynthesis, protect against apoptosis and stimulate replication/neogenesis of beta-cells. Incretin hormones therefore represent an exciting future multi-action solution to correct beta-cell defect in Type 2 diabetes.

Item Type:Journal article
Faculties and Schools:Faculty of Life and Health Sciences
Faculty of Life and Health Sciences > School of Biomedical Sciences
Research Institutes and Groups:Biomedical Sciences Research Institute
Biomedical Sciences Research Institute > Diabetes
ID Code:2958
Deposited By: Professor Peter Flatt
Deposited On:17 Dec 2009 15:03
Last Modified:09 May 2016 10:48

Repository Staff Only: item control page